Redera, Ledelyn A.

HRN: 21-56-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2022
CEFUROXIME 750MG (VIAL)
06/20/2022
06/27/2022
IVT
750mg
Q8
S/P Repeat LTCS

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: Non-compliant To Guidelines